InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.06
(
-0.09%
)
Bitcoin
66,308.81
(
-0.50%
)
Post# of 252215
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 145
Posts 27600
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: midastouch017 post# 248904

Wednesday, 09/20/2023 4:17:24 AM

Wednesday, September 20, 2023 4:17:24 AM

Post# of 252215
BioLineRx Announces Acceptance of Oral Presentation on Pilot Phase Data from Phase 2
Combination Clinical Trial with Motixafortide in First-Line PDAC at AACR Special Conference
on Pancreatic Cancer.

Abstracts to be Published on American Association of Cancer Research (AACR)
Virtual Meeting Platform at 5:30 pm EDT on Wednesday, September 27, 2023

Oral Presentation on Thursday, September 28, 2023, in Boston, Massachusetts

https://finance.yahoo.com/news/biolinerx-announces-acceptance-oral-presentation-110000805.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up